Clinical Advances in Psoriasis Management

Dear Colleagues,

Psoriasis is a chronic inflammatory skin disease, affecting up to 2–3% of the worldwide population, with considerable physical and emotional burdens. Psoriasis management is challenging, particularly for moderate-to-severe forms of the disease. Moreover, several comorbidities (e.g., psoriatic arthritis, inflammatory bowel disease, cardiovascular diseases, obesity, psychological and psychiatric disorders, uveitis, etc.) may be associated with psoriatic disease, necessitating early treatment to prevent systemic complications. In this context, recent knowledge on psoriasis pathogenesis led to the development of new selective drugs, which showed promising results in terms of efficacy with a safe profile.

Aim and the Scope of the Special Issue: This Special Issue offers a comprehensive overview of recent breakthroughs in psoriasis management, from novel biologic agents and small molecules to innovative delivery methods and personalized treatment approaches. We explore the promise of precision medicine, emphasizing the importance of tailoring therapies to individual patient profiles for enhanced outcomes and reduced side effects.

Dr. Sara Cacciapuoti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• psoriasis
• treatments
• personalized medicine
• drug development